Losartan Potassium
Product Images NDC 61919-030

3 FDA label images from Direct Rx · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 61919-030). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Direct Rx, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Structure)

Image Description (Structure)
Chemical structure of the active ingredient in LOSARTAN POTASSIUM, showing a complex arrangement of rings including a chlorinated pyrimidine and a biphenyl group attached to a tetrazole ring, with an associated potassium ion (K+).*
FDA Label Image

Image Description (Warning)

Image Description (Warning)
A drug safety warning panel titled 'Warning: fetal toxicity' for losartan potassium. It advises discontinuing losartan potassium tablets as soon as pregnancy is detected and warns that drugs acting on the renin-angiotensin system may cause injury and death to a developing fetus, referencing additional warnings on fetal toxicity.*
FDA Label Image

030 (Losartan030)

030 (Losartan030)
LOSARTAN POTASSIUM 50mg tablet bottle label by Direct RX. The label states 30 tablets per bottle, generic for Cozzar, each tablet contains 50mg of losartan potassium. The package includes lot number, discard after date 07/17, and warnings such as "Keep out of reach of children" and "May cause dizziness." The label also provides NDC 61919-030-30 and packaging details from Alpharetta, GA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.